HCW Biologics Inc

NASDAQ HCWB

Data sourced from iex and EODHD
Download Data

HCW Biologics Inc Key Metrics 2020 - 2024

This table shows the Key Metrics for HCW Biologics Inc going from 2020 until 2024. Key metrics are specific quantitative measures used to assess the performance and progress of a company, often tailored to its industry and objectives, providing insights into growth, profitability, and operational efficiency.
Key Metrics Trend Unit 2024-03-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Accounts Payable Turnover Ratio
R 0.21 0.27 0.68 0.99 2.03 1.75 1.43 1.05 0.00 6.60 8.80 13.20 26.39 - - -
Accounts Receivable Turnover Ratio
R 0.86 1.20 2.34 2.44 3.81 3.01 1.74 1.41 0.00 0.41 0.55 0.82 1.64 - - -
Asset Coverage Ratio
R - - - - - - - - - - - - - - - -
Asset Turnover Ratio
R 0.09 0.05 0.04 0.04 0.07 0.05 0.04 0.03 0.00 0.13 0.17 0.26 0.51 - - -
Average Collection Period
R 124.31 56.48 731.39 737.72 128.82 143.93 187.58 46.75 - 140.42 140.42 140.42 140.42 - - -
Book Value Per Share
R 0.37 0.66 0.98 1.11 1.23 1.40 1.56 1.30 1.04 0.73 0.37 0.42 0.50 - - -
Capital Expenditure To Sales
% 280.64 73.85 383.60 321.84 142.72 188.59 1.80 0.76 - 0.89 0.89 0.89 0.89 - - -
Cash Dividend Coverage Ratio
R - - - - - -1.20 -26.00 -26.00 -26.00 -50.79 - - - - - -
Cash Flow Coverage Ratio
R -5,348.17 -65.11 -114.29 -1,395.10 -1,386.85 -1,342.85 -1,817.49 -677.36 -675.19 -4,604.50 -6,476.52 -6,476.52 -6,507.95 -3,864.99 -96.95 -96.95
Cash Interest Coverage Ratio
R -2,737.03 -58.52 -84.49 -1,363.12 -1,355.65 -1,312.44 -1,810.78 -676.76 -674.62 -4,563.91 -6,342.70 -6,342.70 -6,372.58 -3,721.98 -92.25 -92.25
Cash Per Share
R 0.10 0.31 0.52 0.57 0.57 0.52 0.46 0.39 0.31 0.29 0.21 0.25 0.30 - - -
Cash Ratio
R 0.41 2.07 6.17 9.13 11.31 10.69 9.41 6.34 4.42 5.27 4.92 6.77 8.45 - - -
Cash Return on Assets (CROA)
R -0.14 -0.16 -0.11 -0.07 -0.05 -0.05 -0.06 -0.07 -0.09 -0.13 -0.14 -0.17 -0.23 - - -
Cash Return on Equity (CROE)
R -0.29 -0.23 -0.15 -0.08 -0.06 -0.05 -0.06 -0.08 -0.10 -0.15 -0.16 -0.19 -0.25 - - -
Cash Return on Invested Capital (CROIC)
R -0.20 -0.19 -0.12 -0.07 -0.06 -0.05 -0.06 -0.08 -0.10 -0.15 -0.16 -0.19 -0.25 - - -
Cash Return on Investment (CROI)
R - -3.49 -0.42 -0.24 -0.17 -0.11 -0.10 -0.15 -0.18 -0.22 -0.31 - - - - -
Cash Taxes
M 5 0 0 0 0 2 2 2 1 - - - - - - -
Cash to Debt Ratio
R 0.43 - 1.74 1.74 1.89 2.03 - - - - - - - - - -
Current Assets to Total Assets Ratio
R 0.22 0.39 0.62 0.68 0.69 0.70 0.75 0.76 0.76 0.77 0.77 0.77 0.79 - - -
Current Liabilities Ratio
R 0.31 0.15 0.08 0.06 0.04 0.03 0.03 0.11 0.13 0.13 0.16 0.08 0.07 - - -
Current Liabilities to Total Liabilities Ratio
R 0.58 0.46 0.35 0.48 0.60 0.77 0.96 0.98 1.00 1.00 1.00 1.00 1.00 - - -
Current Ratio
R 0.73 2.56 8.76 15.23 20.26 21.74 23.16 16.20 11.33 10.00 7.27 9.71 12.14 - - -
Days in Inventory
R 64.59 153.24 2,541.12 2,684.91 509.25 588.82 749.06 311.41 - - - - - - - -
Days Inventory Outstanding (DIO)
R 0.00 278.53 4,007.75 4,205.38 822.63 938.71 1,165.69 555.31 - - - - - - - -
Days Payable Outstanding (DPO)
R 625.64 504.16 4,198.20 3,907.95 338.35 312.13 290.34 204.23 - - - - - - - -
Days Sales Outstanding (DSO)
R 135.93 90.64 700.58 666.69 132.26 138.47 171.83 64.75 - 222.57 222.57 222.57 222.57 - - -
Debt to Asset Ratio
R 0.30 - 0.27 0.27 0.26 0.25 - - - - - - - - - -
Debt to Capital Ratio
R 0.38 - 0.26 0.26 0.24 0.23 - - - - - - - - - -
Debt to EBITDA Ratio
R -0.44 - -2.72 -2.72 -2.80 -3.35 - - - - - - - - - -
Debt to Equity Ratio
R 0.63 - 0.35 0.35 0.32 0.30 - - - - - - - - - -
Debt to Income Ratio
R -1.96 - -2.80 -2.80 -2.89 -3.39 - - - - - - - - - -
Debt to Tangible Net Worth Ratio
R - - - - - - - - - - - - - - - -
Dividend Coverage Ratio
R - - - - - -1.12 -20.88 -20.88 -20.88 -40.63 - - - - - -
Dividend Payout Ratio
% - - - - - -88.93 -45.70 -45.70 -45.70 -2.46 - - - - - -
Dividend Per Share
R - - - - - 0.10 0.05 0.05 0.05 0.00 - - - - - -
EBIT to Fixed Assets Ratio
R -0.53 -0.33 -0.43 -1.30 -1.65 -2.21 -2.93 -2.46 -2.56 -1.54 -0.98 -0.48 1.28 - - -
EBIT to Total Assets Ratio
R -0.38 -0.14 -0.11 -0.10 -0.08 -0.06 -0.06 -0.09 -0.15 -0.10 -0.11 -0.07 0.13 - - -
EBITDA Coverage Ratio
R -7,374.31 -47.80 -99.56 -1,717.92 -1,707.07 -1,641.56 -2,022.98 -525.80 -524.42 1,924.87 143.99 143.99 110.99 -3,504.79 -104.72 -104.72
EBITDA Per Share
R -0.29 -0.13 -0.13 -0.12 -0.10 -0.09 -0.09 -0.09 -0.10 -0.06 -0.05 -0.05 -0.05 -0.09 -0.09 -0.08
Equity Multiplier
R 2.12 1.49 1.29 1.20 1.13 1.08 1.04 1.15 1.17 1.18 1.22 1.09 1.07 - - -
Equity to Assets Ratio
R 0.47 0.67 0.78 0.84 0.89 0.93 0.96 0.89 0.87 0.87 0.84 0.92 0.93 - - -
Free Cash Flow Margin
R -5.75 -7.29 -30.35 -27.44 -4.06 -4.46 -3.24 -0.52 - -0.87 -0.87 -0.87 -0.87 - - -
Free Cash Flow Per Share
R -0.21 -0.17 -0.22 -0.16 -0.14 -0.15 -0.10 -0.09 -0.09 -0.09 -0.07 -0.09 -0.09 -0.08 -0.07 -0.07
Free Cash Flow to Equity (FCFE)
M - - - - - - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
M -8 -6 -31 -23 -20 -19 -7 -4 -3 - - - - - - -
Gross Profit Per Share
R 0.00 0.00 0.01 0.01 0.02 0.02 0.03 0.05 - 0.14 0.14 0.14 0.14 - - -
Gross Profit to Fixed Assets Ratio
R 0.00 0.01 0.02 0.06 0.50 0.66 0.98 1.77 - 2.54 2.54 2.54 2.54 - - -
Gross Profit to Tangible Assets Ratio
R - - - - - - - - - - - - - - - -
Gross Working Capital
M -2 - 64 64 45 20 - - - - - - - - - -
Interest Coverage Ratio
R -7,567.25 -50.71 -104.80 -1,794.89 -1,783.21 -1,714.67 -2,107.91 -542.41 -540.86 1,728.41 -148.67 -148.67 -183.87 -3,676.97 -111.60 -111.60
Interest Expense To Sales
% 0.11 11.20 61.46 57.65 3.30 3.87 2.89 5.66 - 0.01 0.01 0.01 0.01 - - -
Inventory Turnover Ratio
R 1,345,907.00 0.39 0.48 0.44 0.60 0.54 0.43 0.66 - - - - - - - -
Invested Capital
M 20 - 151 151 106 56 - - - - - - - - - -
Liabilities to Equity Ratio
R 1.12 0.49 0.29 0.20 0.13 0.08 0.04 0.15 0.17 0.18 0.22 0.09 0.07 - - -
Long-Term Debt to Equity Ratio
R 0.61 0.27 0.19 0.17 0.16 0.15 - - - - - - - - - -
Long-Term Debt to Total Assets Ratio
R 0.29 0.18 0.14 0.14 0.13 0.13 - - - - - - - - - -
Net Current Asset Value
R -8,647,756.00 2,098,684.00 18,131,611.25 24,252,548.25 28,583,466.25 31,950,594.25 37,264,304.75 30,387,200.50 23,413,193.25 16,660,393.75 8,492,326.00 9,800,041.50 11,147,584.00 - - -
Net Debt to EBITDA Ratio
R -0.15 0.26 2.66 3.73 5.74 6.01 5.68 5.02 2.94 1.02 0.09 -0.85 -3.80 - - -
Net Income Before Taxes
R -11,239,256.32 -4,629,075.88 -4,586,114.39 -4,478,545.75 -3,725,176.00 -3,163,841.75 -2,913,724.33 -2,615,306.00 -3,173,405.00 - - - - - - -
Net Operating Profit After Tax (NOPAT)
R -9,971,980.72 -4,870,998.11 -4,603,455.05 -4,372,042.02 -3,647,699.90 -3,004,106.38 -2,754,992.77 -2,451,986.71 -3,016,919.95 - - - - - - -
Net Working Capital to Total Assets Ratio
R -0.08 0.24 0.54 0.62 0.65 0.66 0.72 0.65 0.64 0.64 0.61 0.69 0.72 - - -
Non-current Assets to Total Assets Ratio
R 0.78 0.61 0.38 0.32 0.31 0.30 0.25 0.24 0.24 0.23 0.23 0.23 0.21 - - -
Non-current Liabilities to Total Liabilities Ratio
R 0.42 0.54 0.65 0.52 0.40 0.25 0.07 0.58 0.56 0.53 0.71 0.00 0.00 - - -
Operating Cash Flow Per Share
R -0.11 -0.16 -0.13 -0.09 -0.07 -0.07 -0.10 -0.09 -0.09 -0.09 -0.07 -0.08 -0.09 -0.08 -0.07 -0.07
Operating Cash Flow To Current Liabilities
R -0.45 -1.03 -1.29 -1.36 -1.44 -1.48 -1.77 -1.24 -1.23 -1.75 -1.63 -2.32 -3.53 - - -
Operating Cash Flow to Debt Ratio
R -0.46 - -0.25 -0.25 -0.24 -0.18 - - - - - - - - - -
Operating Cash Flow to Sales Ratio
% -294.17 -655.17 -2,651.26 -2,422.38 -263.49 -257.17 -321.77 -51.07 - -86.28 -86.28 -86.28 -86.28 - - -
Operating Expense Ratio
% 811.65 615.71 3,564.26 3,580.90 403.12 390.01 463.92 117.73 - 49.73 49.73 49.73 49.73 - - -
Operating Income Per Share
R -0.30 -0.14 -0.14 -0.13 -0.11 -0.09 -0.10 -0.09 -0.11 -0.06 -0.05 -0.05 -0.05 -0.09 -0.09 -0.08
Operating Income to Total Debt
R -1.28 - -0.39 -0.39 -0.38 -0.31 - - - - - - - - - -
Payables Turnover
R 0.22 0.22 0.54 0.72 1.16 1.26 1.38 1.79 - - - - - - - -
Pre-Tax Margin
% -813.31 -567.71 -3,534.71 -3,559.10 -374.45 -351.96 -416.85 -60.33 - 50.27 50.27 50.27 50.27 - - -
Quick Ratio
R 0.73 2.23 8.29 14.53 19.27 20.63 22.05 15.15 10.50 9.27 6.58 9.15 11.60 - - -
Research and Development (R&D) Expense Ratio
% 161.36 195.46 1,502.60 1,546.18 214.03 212.57 245.65 57.41 - 34.38 34.38 34.38 34.38 - - -
Retained Earnings To Equity Ratio
R -5.24 -2.51 -1.41 -1.12 -0.90 -0.75 -0.64 -1.10 -1.36 -1.51 -1.84 -1.45 -1.16 - - -
Retention Ratio
% - - - - - 188.93 145.70 145.70 145.70 102.46 - - - - - -
Return on Assets (ROA)
% -37.46 -13.87 -10.23 -9.36 -7.66 -6.28 -6.24 -9.67 -14.07 -9.24 -9.91 -4.31 13.38 - - -
Return on Capital Employed (ROCE)
% -54.48 -16.04 -11.87 -10.76 -8.27 -6.41 -6.26 -12.12 -18.54 -13.44 -15.39 -7.57 14.32 - - -
Return on Common Equity
% - - -130,360.40 -122,268.10 -117,753.96 -102,130.83 -97,991.21 -554,508.47 -554,508.47 -554,508.47 -554,508.47 - - - - -
Return on Equity (ROE)
% -79.34 -20.69 -13.31 -11.44 -8.84 -6.82 -6.48 -12.33 -17.34 -12.21 -13.76 -5.12 14.31 - - -
Return on Fixed Assets (ROFA)
% -52.22 -33.41 -39.96 -127.47 -172.25 -230.77 -302.75 -256.28 -247.63 -144.84 -85.56 -29.22 127.57 - - -
Return on Gross Investment (ROGI)
% - -308.71 -235.44 -175.93 -104.68 -28.02 -28.41 -63.63 -78.28 -103.65 -171.92 - - - - -
Return on Investment (ROI)
% - -308.71 -40.19 -33.99 -25.31 -15.70 -10.05 -28.43 -35.28 -48.58 -85.96 - - - - -
Return on Net Assets (RONA)
% -40.81 -11.21 -6.67 -5.79 -4.66 -3.81 -3.64 -6.19 -8.88 -6.07 -6.69 -2.77 7.76 - - -
Return on Net Investment (RONI)
% - 104.35 56.10 44.65 16.06 -79.01 - - - - - - - - - -
Return on Sales (ROS)
% -806.69 -578.90 -3,234.48 -3,254.99 -363.46 -351.77 -422.39 -71.65 - 50.27 50.27 50.27 50.27 - - -
Return on Tangible Equity (ROTE)
% - - - - - - - - - - - - - - - -
Return on Total Capital (ROTC)
% -48.81 - -9.42 -9.42 -8.75 -6.87 - - - - - - - - - -
Revenue Per Share
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Sales to Fixed Assets Ratio
R 0.06 0.06 0.09 0.20 0.97 0.94 0.89 0.77 0.00 0.63 0.85 1.27 2.54 - - -
Sales to Operating Cash Flow Ratio
R -0.34 -0.15 -0.30 -0.33 -0.82 -0.73 -0.53 -0.49 0.00 -0.29 -0.29 -0.29 -0.39 0.00 0.00 -
Sales to Total Assets Ratio
R 0.05 0.02 0.02 0.02 0.03 0.03 0.02 0.02 0.00 0.07 0.09 0.13 0.27 - - -
Sales to Working Capital Ratio
R -0.56 0.10 0.04 0.03 0.05 0.04 0.02 0.02 0.00 0.09 0.12 0.18 0.37 - - -
Selling, General, and Administrative (SG&A) Expense Ratio
% 268.59 412.86 2,058.62 2,033.35 187.43 175.22 215.83 59.18 - 13.88 13.88 13.88 13.88 - - -
Short-Term Debt to Equity Ratio
R 0.01 - 0.17 0.17 0.16 0.15 - - - - - - - - - -
Short-Term Debt to Total Assets Ratio
R 0.01 - 0.14 0.14 0.13 0.13 - - - - - - - - - -
Tangible Asset Value Ratio
R - - 0.78 0.84 0.89 0.93 0.96 0.28 -0.35 -0.79 -1.67 -1.55 - - - -
Tangible Book Value per Share
R - - - - - - - - - - - - - - - -
Total Debt to Capital Ratio
R 0.38 - 0.26 0.26 0.24 0.23 - - - - - - - - - -
Total Liabilities to Total Assets Ratio
R 0.53 0.33 0.22 0.16 0.11 0.07 0.04 0.11 0.13 0.13 0.16 0.08 0.07 - - -
Working Capital to Current Liabilities Ratio
R -0.27 1.56 7.76 14.23 19.26 20.74 22.16 15.20 10.33 9.00 6.27 8.71 11.14 - - -
Working Capital To Sales Ratio
R -0.57 2.95 167.30 179.61 30.81 33.35 42.73 11.70 - 2.72 2.72 2.72 2.72 - - -
Working Capital Turnover Ratio
R -0.56 0.10 0.04 0.03 0.05 0.04 0.02 0.02 0.00 0.09 0.12 0.18 0.37 - - -

StockViz Staff

September 20, 2024

Any question? Send us an email